Advertisement

Topics

Tolero Pharmaceuticals, Inc. Company Profile

14:59 EST 9th December 2018 | BioPortfolio

Tolero Pharmaceuticals, Inc., a clinical-stage company, is developing treatments to improve and extend the lives of patients with serious hematological diseases. Our diverse pipeline targets important biological drivers of blood disorders to treat acute and chronic leukemias and anemia. We are well positioned to make a major contribution to clinical strategies that match the right patient with the right drug to alleviate life-threatening blood disorders. For more information, please visit www.toleropharmaceuticals.com.


News Articles [325 Associated News Articles listed on BioPortfolio]

Tolero Pharmaceuticals and AbbVie partner to develop AML therapy

Biopharmaceutical firm Tolero Pharmaceuticals and AbbVie have formed a clinical research alliance to evaluate venetoclax and alvocidib combination for relapsed...Read More... The post Tolero Pharmaceu...

Deals and M&As this week: Tolero Pharmaceuticals, BioNTech, Novo Nordisk

Tolero Pharmaceuticals has entered a clinical research collaboration with AbbVie for the development of a therapy for acute myeloid leukaemia...Read More... The post Deals and M&As this week: Tol...

Tolero Pharmaceuticals Presents Updated Clinical Data from Ongoing Phase 2 Zella 201 Study ...

SALT LAKE CITY, Dec. 1, 2018 /PRNewswire/ -- Tolero Pharmaceuticals, Inc., a clinical-stage company focused on developing novel therapeutics for hematological and oncological diseases, today Read mor...

AbbVie, Tolero to assess Venclexta combo for acute myeloid leukemia

AbbVie and Tolero Pharmaceuticals have partnered to evaluate the safety and efficacy of Venclexta, or venetoclax, in combinat -More- 

Tolero doses first patient in Phase l trial of TP-0184

Tolero Pharmaceuticals has dosed the first patient in a Phase l trial to examine TP-0184 for the treatment of patients...Read More... The post Tolero doses first patient in Phase l trial of TP-0184 ap...

Tolero enrols first patient in Phase Ib/II trial of alvocidib

Tolero Pharmaceuticals has enrolled the first patient in its Phase Ib/II Zella 102 trial. The trial will examine alvocidib in...Read More... The post Tolero enrols first patient in Phase Ib/II trial o...

AbbVie, Tolero enter AML trial collaboration

In a clinical trial collaboration, Tolero Pharmaceuticals Inc. is investigating a therapy that combines its own alvocidib with AbbVie Inc.’s venetoclax for relapsed/refractory acute myeloid leukemia...

Tolero Pharma signs clinical research pact with AbbVie for AML trial

Tolero Pharmaceuticals, Inc, a clinical─stage biopharmaceutical company focused on developing treatments for haematologic and oncologic diseases, has entered into a clinical research collaboration w...

Drugs and Medications [270 Associated Drugs and Medications listed on BioPortfolio]

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash

Bacitracin [Qualitest Pharmaceuticals]

Bacitracin Ointment, USP

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash Purified Water, 98.3% Ophthalmic Solution Eyewash

Antacid [Major Pharmaceuticals]

Major Pharmaceuticals Antacid Tablets Drug Facts

Eyewash station additive concentrate [Niagara Pharmaceuticals Inc.]

EYEWASH STATION ADDITIVE CONCENTRATE

PubMed Articles [132 Associated PubMed Articles listed on BioPortfolio]

Swimming activity in zebrafish larvae exposed to veterinary antiparasitic pharmaceuticals.

Veterinary antiparasitic pharmaceuticals have been detected in surface waters and several of these pharmaceuticals act on the nervous system on the target organisms implying that neurological effects ...

Chiral pharmaceuticals: Environment sources, potential human health impacts, remediation technologies and future perspective.

Chiral pharmaceuticals (CPs), including non-steroid anti-inflammatory drugs (NSAIDs), β-blockers and some herbicide and pesticides, are widely used in aquaculture, clinical treatment and many other f...

Assessment of 83 pharmaceuticals in WWTP influent and effluent samples by UHPLC-MS/MS: Hourly variation.

The removal efficiency of pharmaceuticals in wastewater treatment plants (WWTPs) is variable and some of these compounds pass these plants almost intact and others presenting a removal efficiency clos...

Letter--Incorporating Real-World Evidence and Patient Value Criteria into Value-Based Frameworks for Relapsed/Refractory Multiple Myeloma.

Orlowski has received research funding from Amgen, BioTheryX, Bristol-Myers Squibb, Celgene Corporation, and Takeda Pharmaceuticals; honoraria from Amgen, Bristol-Myers Squibb, Celgene Corporation, Ja...

Effects of pharmaceuticals on microbial communities and activity of soil enzymes in mesocosm-scale constructed wetlands.

Cyperus alternifolius based mesocosm-scale constructed wetland was employed to remove pharmaceuticals. We investigated the microbial community composition using phosphor lipid fatty acids (PFLAs) anal...

Clinical Trials [228 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic®20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sep...

Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic 20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sepa...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

Companies [1338 Associated Companies listed on BioPortfolio]

MannKind Corporation and Tolero Pharmaceuticals

Tolero is a biopharmaceutical company dedicated to the discovery and development of novel therapeutics to treat and cure cancer and other life-threatening diseases. Tolero has use...

Tolero Pharmaceuticals, Inc.

Tolero Pharmaceuticals, Inc., a clinical-stage company, is developing treatments to improve and extend the lives of patients with serious hematological diseases. Our diverse pipel...

Maelor Pharmaceuticals Ltd.

Maelor is a publicly listed (AIM:MLR) specialist critical care pharmaceuticals and devices company. The Company has developed an expertise in bringing both pharmaceuticals and devices to the market as...

Excaliard Pharmaceuticals, Inc.

Excaliard Pharmaceuticals, Inc., is a venture capital-funded biotechnology company founded in 2007 focused on the development and commercialization of novel and innovative drugs for the amelioration o...

Serenity Pharmaceuticals

Founded in 2007 and located in Milford, Pennsylvania, Serenity Pharmaceuticals is focused on developing products that address urinary conditions that impact the health and well-be...

More Information about "Tolero Pharmaceuticals, Inc." on BioPortfolio

We have published hundreds of Tolero Pharmaceuticals, Inc. news stories on BioPortfolio along with dozens of Tolero Pharmaceuticals, Inc. Clinical Trials and PubMed Articles about Tolero Pharmaceuticals, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Tolero Pharmaceuticals, Inc. Companies in our database. You can also find out about relevant Tolero Pharmaceuticals, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...


Corporate Database Quicklinks



Searches Linking to this Company Record